SKI Market

A+| A| A-|

Indian Indices

Sensex

76,070.84 567.99
( 0.75%)

Global Indices

Nasdaq

46,970.79 391.31
(0.84%)

Dow Jones

6,721.52 68.33
(1.03%)

Hang Seng

53,528.27 -222.88
(-0.41%)

Nikkei 225

10,338.98 77.83
(0.76%)

Forex

USD-INR

92.32 0.03
(0.03%)

EUR-INR

105.40 -1.04
(-0.98%)

GBP-INR

122.05 -1.31
(-1.06%)

JPY-INR

0.58 0.00
(-0.37%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aqylon Nexus Ltd

Industry : Entertainment / Electronic Media Software

BSE Code

ISIN Demat

Book Value()

530943

INE416A01051

0.0325958

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AQYLON

2024.77

EPS(TTM)

Face Value()

Div & Yield %

Back

Shukra Pharmaceuticals standalone net profit rises 544.30% in the December 2025 quarter

Feb 04,2026

Net profit of Shukra Pharmaceuticals rose 544.30% to Rs 20.36 crore in the quarter ended December 2025 as against Rs 3.16 crore during the previous quarter ended December 2024. Sales rose 269.85% to Rs 39.13 crore in the quarter ended December 2025 as against Rs 10.58 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	39.13	10.58	270
OPM %	69.31	37.15	-
PBDT	27.66	4.79	477
PBT	26.82	4.09	556
NP	20.36	3.16	544

76,070.84 567.99 ( 0.75%)

46,970.79 391.31 (0.84%)

6,721.52 68.33 (1.03%)

53,528.27 -222.88 (-0.41%)

10,338.98 77.83 (0.76%)

92.32 0.03 (0.03%)

105.40 -1.04 (-0.98%)

122.05 -1.31 (-1.06%)

0.58 0.00 (-0.37%)